Check out our most popular compounded medications! Get Started
Morphine Sulfate 180 mg Slow Release Capsules are formulated with Methocel E4M, a controlled-release polymer. This design allows for the gradual release of the encapsulated medication over an extended period, providing sustained therapeutic effects. This formulation is used to treat various types of pain including chronic, cancer, postoperative, neuropathic, and arthritis pain. The slow release mechanism reduces dosing frequency and improves patient compliance for medications requiring a controlled and prolonged release profile.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Morphine Sulfate 180 mg Slow Release Capsules are a potent, long-acting opioid analgesic designed to provide sustained relief from moderate to severe pain. This formulation is specifically engineered with Methocel E4M, a type of controlled-release polymer, to gradually release the encapsulated medication over an extended period of time. This slow release mechanism offers consistent therapeutic effects, reduces the frequency of dosing, and improves patient compliance, particularly for medications requiring a controlled and prolonged release profile.
This formulation is particularly beneficial for patients suffering from pain associated with cancer, post-operative discomfort, and chronic pain conditions.
However, this formulation is not recommended for patients with acute pain, as the slow release mechanism may not provide immediate pain relief. Patients should also be aware of potential side effects, which may include drowsiness, dizziness, and confusion. It is advised not to drive or operate machinery while taking this medication. Furthermore, this medication has the potential to be habit-forming and should not be taken for longer than prescribed.
Healthcare providers prescribing Morphine Sulfate 180 mg Slow Release Capsules should exercise caution in patients with a history of substance abuse or addiction due to the long-acting nature of this opioid analgesic. Additionally, this medication may cause respiratory depression and should be used with caution in patients with respiratory conditions.
If you have any questions or concerns about Morphine Sulfate 180 mg Slow Release Capsules, please do not hesitate to contact us at Bayview Pharmacy. We are committed to providing comprehensive information to ensure the safe and appropriate use of this medication.
Morphine Sulfate 180 mg Slow Release Capsules are a potent analgesic formulation designed for the management of moderate to severe pain. These capsules are formulated with Methocel E4M, a type of controlled-release polymer. This innovative technology allows for the gradual release of the encapsulated medication over an extended period, providing sustained therapeutic effects. This slow-release mechanism reduces the frequency of dosing and promotes improved patient compliance, particularly beneficial for medications requiring a controlled and prolonged release profile.
It is crucial to note that Morphine Sulfate 180 mg Slow Release Capsules should not be administered to patients with a known hypersensitivity to morphine or other opioids. Additionally, they should not be used in patients with significant respiratory depression. Regular monitoring for signs of respiratory depression, sedation, and hypotension is recommended when using this medication. Furthermore, vigilance for signs of opioid addiction, abuse, and misuse is necessary.
Special caution is advised when prescribing Morphine Sulfate 180 mg Slow Release Capsules to patients with renal or hepatic impairment, as well as in elderly patients. These populations may require careful dosage adjustments and close monitoring. Patients should be counseled to avoid alcohol and other CNS depressants while taking this medication due to the risk of additive sedative effects. Additionally, patients should be advised to refrain from activities requiring mental alertness, such as driving or operating machinery, until they fully understand how this medication affects them.
For any further queries or concerns regarding Morphine Sulfate 180 mg Slow Release Capsules, please do not hesitate to reach out.
Morphine Sulfate 180 mg Slow Release Capsules are a potent, extended-release opioid medication designed to manage moderate to severe pain. These capsules are formulated with Methocel E4M, a type of controlled-release polymer, which ensures the gradual release of the encapsulated medication over an extended period. This slow-release mechanism provides a sustained therapeutic effect, reduces the frequency of dosing, and improves patient compliance, particularly for medications requiring a controlled and prolonged release profile.
The capsules are administered orally, typically once a day, and should be consumed with food. It is crucial to adhere to the prescribed dosage and frequency as directed by your healthcare provider. Overdosing or frequent intake can lead to adverse effects and should be avoided.
Morphine Sulfate 180 mg Slow Release Capsules are versatile in their application, providing relief from chronic pain, cancer pain, post-operative pain, and pain associated with end-stage renal disease, sickle cell anemia, among other conditions.
While effective, Morphine Sulfate 180 mg Slow Release Capsules may cause side effects such as nausea, vomiting, constipation, dizziness, drowsiness, confusion, and in severe cases, respiratory depression, which can be life-threatening. It is essential to communicate with your healthcare provider about any side effects experienced while on this medication.
If you have any queries or concerns about Morphine Sulfate 180 mg Slow Release Capsules, do not hesitate to seek professional advice.
Morphine Sulfate 180 mg Slow Release Capsules are a potent analgesic formulation designed to provide extended pain relief. These capsules are formulated with Methocel E4M, a type of controlled-release polymer, which ensures the gradual release of the active ingredient over an extended period. This slow-release mechanism offers sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance, particularly for medications requiring a controlled and prolonged release profile.
They can also be beneficial in managing dyspnea, or shortness of breath, in patients with advanced cancer. Furthermore, Morphine Sulfate 180 mg Slow Release Capsules can be used to treat opioid-induced constipation and to reduce the severity of withdrawal symptoms in patients with opioid dependence.
However, caution should be exercised when using Morphine Sulfate 180 mg Slow Release Capsules in patients with renal or hepatic impairment, as well as in patients with a history of substance abuse. Close monitoring for signs of respiratory depression, sedation, and constipation is recommended. If you have any questions about the use of Morphine Sulfate 180 mg Slow Release Capsules for any of these indications, please do not hesitate to reach out for further information.
Morphine Sulfate 180 mg Slow Release Capsules is a medication formulated with Methocel E4M, a type of controlled-release polymer. This formulation is designed to gradually release the encapsulated medication over an extended period of time.
The controlled-release polymer, Methocel E4M, is designed to release the medication gradually over an extended period of time. This offers sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance for medications requiring a controlled and prolonged release profile.
A slow-release formulation offers several benefits. It provides sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance. This is particularly beneficial for medications that require a controlled and prolonged release profile.
The frequency of dosing will depend on your doctor's prescription. However, due to the slow-release formulation, the frequency of dosing is typically reduced compared to other formulations.
'Improved patient compliance' means that patients are more likely to take the medication as prescribed. This is because the slow-release formulation reduces the frequency of dosing, making it easier for patients to adhere to their medication regimen.
Methocel E4M is a type of controlled-release polymer used in the formulation of Morphine Sulfate 180 mg Slow Release Capsules. It is designed to gradually release the encapsulated medication over an extended period of time, offering sustained therapeutic effects.
No, Morphine Sulfate 180 mg Slow Release Capsules should not be broken or crushed. Doing so can interfere with the controlled-release mechanism and may lead to rapid release and absorption of a potentially fatal dose of morphine.
If you miss a dose of Morphine Sulfate 180 mg Slow Release Capsules, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.
Like all medications, Morphine Sulfate 180 mg Slow Release Capsules can cause side effects. These may include constipation, nausea, sleepiness, vomiting, tiredness, headache, dizziness, abdominal pain. You should contact your doctor if you experience any unusual or severe side effects.
No, you should not drink alcohol while taking Morphine Sulfate 180 mg Slow Release Capsules. Combining alcohol with this medication can increase your risk of dangerous side effects, including slowed or stopped breathing, and death.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
This preparation is a controlled substance. Additional prescribing, refill, and shipping restrictions apply, and the states Bayview can dispense it to are narrower than for non-controlled preparations.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take 1 capsule by mouth
